Ohta M - Search Results

1

New thiazole derivatives as potent and selective 5-hydroxytriptamine 3 (5-HT3) receptor agonists for the treatment of constipation.

Imanishi N, Iwaoka K, Koshio H, Nagashima SY, Kazuta K, Ohta M, Sakamoto S, Ito H, Akuzawa S, Kiso T, Tsukamoto S, Mase T. Imanishi N, et al. Among authors: ohta m. Bioorg Med Chem. 2003 Apr 3;11(7):1493-502. doi: 10.1016/s0968-0896(02)00557-6. Bioorg Med Chem. 2003. PMID: 12628674

2

Synthesis and structure-activity relationships of new carbonyl guanidine derivatives as novel dual 5-HT2B and 5-HT7 receptor antagonists.

Moritomo A, Yamada H, Watanabe T, Itahana H, Akuzawa S, Okada M, Ohta M. Moritomo A, et al. Among authors: ohta m. Bioorg Med Chem. 2013 Dec 15;21(24):7841-52. doi: 10.1016/j.bmc.2013.10.010. Epub 2013 Oct 21. Bioorg Med Chem. 2013. PMID: 24189186

3

Synthetic studies on novel Syk inhibitors. Part 1: Synthesis and structure-activity relationships of pyrimidine-5-carboxamide derivatives.

Hisamichi H, Naito R, Toyoshima A, Kawano N, Ichikawa A, Orita A, Orita M, Hamada N, Takeuchi M, Ohta M, Tsukamoto S. Hisamichi H, et al. Among authors: ohta m. Bioorg Med Chem. 2005 Aug 15;13(16):4936-51. doi: 10.1016/j.bmc.2005.05.033. Bioorg Med Chem. 2005. PMID: 15990316

4

(+)-(2R,5S)-4-[4-cyano-3-(trifluoromethyl)phenyl]-2,5-dimethyl-N-[6-(trifluoromethyl)pyridin-3- yl]piperazine-1-carboxamide (YM580) as an orally potent and peripherally selective nonsteroidal androgen receptor antagonist.

Kinoyama I, Taniguchi N, Toyoshima A, Nozawa E, Kamikubo T, Imamura M, Matsuhisa A, Samizu K, Kawanimani E, Niimi T, Hamada N, Koutoku H, Furutani T, Kudoh M, Okada M, Ohta M, Tsukamoto S. Kinoyama I, et al. Among authors: ohta m. J Med Chem. 2006 Jan 26;49(2):716-26. doi: 10.1021/jm050293c. J Med Chem. 2006. PMID: 16420057

5

Novel potent and selective calcium-release-activated calcium (CRAC) channel inhibitors. Part 1: synthesis and inhibitory activity of 5-(1-methyl-3-trifluoromethyl-1H-pyrazol-5-yl)-2-thiophenecarboxamides.

Yonetoku Y, Kubota H, Okamoto Y, Toyoshima A, Funatsu M, Ishikawa J, Takeuchi M, Ohta M, Tsukamoto S. Yonetoku Y, et al. Among authors: ohta m. Bioorg Med Chem. 2006 Jul 15;14(14):4750-60. doi: 10.1016/j.bmc.2006.03.024. Epub 2006 Mar 31. Bioorg Med Chem. 2006. PMID: 16580212

6

Novel potent and selective calcium-release-activated calcium (CRAC) channel inhibitors. Part 2: Synthesis and inhibitory activity of aryl-3-trifluoromethylpyrazoles.

Yonetoku Y, Kubota H, Okamoto Y, Ishikawa J, Takeuchi M, Ohta M, Tsukamoto S. Yonetoku Y, et al. Among authors: ohta m. Bioorg Med Chem. 2006 Aug 1;14(15):5370-83. doi: 10.1016/j.bmc.2006.03.039. Epub 2006 Apr 17. Bioorg Med Chem. 2006. PMID: 16616503

7

Synthesis and biological evaluation of 4-morpholino-2-phenylquinazolines and related derivatives as novel PI3 kinase p110alpha inhibitors.

Hayakawa M, Kaizawa H, Moritomo H, Koizumi T, Ohishi T, Okada M, Ohta M, Tsukamoto S, Parker P, Workman P, Waterfield M. Hayakawa M, et al. Among authors: ohta m. Bioorg Med Chem. 2006 Oct 15;14(20):6847-58. doi: 10.1016/j.bmc.2006.06.046. Epub 2006 Jul 11. Bioorg Med Chem. 2006. PMID: 16837202

8

Potent and selective TF/FVIIa inhibitors containing a neutral P1 ligand.

Miura M, Seki N, Koike T, Ishihara T, Niimi T, Hirayama F, Shigenaga T, Sakai-Moritani Y, Kawasaki T, Sakamoto S, Okada M, Ohta M, Tsukamoto S. Miura M, et al. Among authors: ohta m. Bioorg Med Chem. 2006 Dec 1;14(23):7688-705. doi: 10.1016/j.bmc.2006.08.010. Epub 2006 Aug 30. Bioorg Med Chem. 2006. PMID: 16942884

9

Synthesis and biological evaluation of imidazo[1,2-a]pyridine derivatives as novel PI3 kinase p110alpha inhibitors.

Hayakawa M, Kaizawa H, Kawaguchi K, Ishikawa N, Koizumi T, Ohishi T, Yamano M, Okada M, Ohta M, Tsukamoto S, Raynaud FI, Waterfield MD, Parker P, Workman P. Hayakawa M, et al. Among authors: ohta m. Bioorg Med Chem. 2007 Jan 1;15(1):403-12. doi: 10.1016/j.bmc.2006.09.047. Epub 2006 Oct 16. Bioorg Med Chem. 2007. PMID: 17049248

10

Design, synthesis and biological activity of selective and orally available TF/FVIIa complex inhibitors containing non-amidine P1 ligands.

Miura M, Seki N, Koike T, Ishihara T, Niimi T, Hirayama F, Shigenaga T, Sakai-Moritani Y, Tagawa A, Kawasaki T, Sakamoto S, Okada M, Ohta M, Tsukamoto S. Miura M, et al. Among authors: ohta m. Bioorg Med Chem. 2007 Jan 1;15(1):160-73. doi: 10.1016/j.bmc.2006.09.071. Epub 2006 Oct 4. Bioorg Med Chem. 2007. PMID: 17064913

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,103 results

Search Page